首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Substance abuse

缩写:SUBST ABUS

ISSN:0889-7077

e-ISSN:1547-0164

IF/分区:2.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1162
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jason M Glanz,Stanley Xu,Komal J Narwaney et al. Jason M Glanz et al.
Background: Tapering long-term opioid therapy is an increasingly common practice, yet rapid opioid dose reductions may increase the risk of overdose. The objective of this study was to compare overdose risk following opio...
Michael A Incze,Sonia L Sehgal,Annika Hansen et al. Michael A Incze et al.
Background: Care transitions represent vulnerable events for patients newly initiating medications for opioid use disorder (MOUD). Multidisciplinary primary care-based transition clinics may improve care linkage and reten...
Brendan Saloner,Barbara Andraka-Christou,Bradley D Stein et al. Brendan Saloner et al.
The 2023 Consolidated Appropriations Act repealed the special waiver for prescribing buprenorphine to patients with opioid use disorder, a bipartisan goal long sought by advocates. The change has symbolic importance in recognizing that bupr...
Nathalia Munck Machado,Rick Cagan,Babalola Faseru et al. Nathalia Munck Machado et al.
Background: People with mental health (MH) and substance use disorders (SUD) have high rates of tobacco use and tobacco-related mortality. They want to stop smoking and studies have shown they can quit, but few behavioral...
Beth Ann Griffin,Irineo Cabreros,Brendan Saloner et al. Beth Ann Griffin et al.
Background: Increasing buprenorphine access is critical to facilitating effective opioid use disorder treatment. Buprenorphine prescriber numbers have increased substantially, but most clinicians who start prescribing bup...
Matthew R Heerema,Alicia S Ventura,Samantha C Blakemore et al. Matthew R Heerema et al.
Introduction: Reducing substance-related morbidity requires an educated and well-supported workforce. The New England Office Based Addiction Treatment Extension for Community Healthcare Outcomes (NE OBAT ECHO) began in 20...
Megan S Schuler,Brendan Saloner,Adam J Gordon et al. Megan S Schuler et al.
Background: Buprenorphine is a key medication to treat opioid use disorder (OUD). Since its approval in 2002, buprenorphine access has grown markedly, spurred by major federal and state policy changes. This study characte...
Jessica J Wyse,Travis I Lovejoy,Adam J Gordon et al. Jessica J Wyse et al.
Background: Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are ...
Marina Gaeta Gazzola,Iain D Carmichael,Nicholaus J Christian et al. Marina Gaeta Gazzola et al.
Background: Homelessness is an important social determinant of health (SDOH), impacting health outcomes for many medical conditions. Although homelessness is common among people with opioid use disorder (OUD), few studies...